Research Area: LMs on diverse modalities and novel applications
Keywords: in-context learning, drug synergy prediction, inverse drug design, precision medicine
TL;DR: We investigate the application of language models and in-context learning to drug synergy prediction and design.
Abstract: Predicting synergistic drug combinations can help accelerate discovery of cancer treatments, particularly therapies personalized to a patient's specific tumor via biopsied cells. In this paper, we propose a novel setting and models for *in-context drug synergy learning*. We are given a small "personalized dataset" of 10-20 drug synergy relationships in the context of specific cancer cell targets. Our goal is to predict additional drug synergy relationships in that context. Inspired by recent work that pre-trains a GPT language model (LM) to "in-context learn" common function classes, we devise novel pre-training schemes that enable a GPT model to in-context learn "drug synergy functions". Our model---which does not use any textual corpora, molecular fingerprints, protein interaction or any other domain-specific knowledge--- is able to achieve competitive results. We further integrate our in-context approach with a genetic algorithm to optimize model prompts and select synergy candidates to test after conducting a patient biopsy. Finally, we explore a novel task of inverse drug design which can potentially enable the design of drugs that synergize specifically to target a given patient's "personalized dataset'". Our findings could have an important impact on precision cancer medicine, and also raise intriguing questions on non-textual pre-training for LMs.
Code Of Ethics: I acknowledge that I and all co-authors of this work have read and commit to adhering to the COLM Code of Ethics on https://colmweb.org/CoE.html
Author Guide: I certify that this submission complies with the submission instructions as described on https://colmweb.org/AuthorGuide.html
Submission Number: 520
Loading